Published in J Cell Biol on April 27, 2015
When things go wrong: correcting the scientific record. EMBO J (2015) 0.88
From RAS to RHO: The making of the great cell biologist Alan Hall (1952-2015). J Cell Biol (2015) 0.75
Reproducibility and transparency in biomedical sciences. Oral Dis (2016) 0.75
Why most published research findings are false. PLoS Med (2005) 41.68
Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov (2011) 22.33
Drug development: Raise standards for preclinical cancer research. Nature (2012) 20.64
The selectivity of protein kinase inhibitors: a further update. Biochem J (2007) 15.73
Policy: NIH plans to enhance reproducibility. Nature (2014) 15.71
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force. J Cell Biol (2013) 3.77
Sorting out the FACS: a devil in the details. Cell Rep (2014) 1.54
Off-target effects dominate a large-scale RNAi screen for modulators of the TGF-β pathway and reveal microRNA regulation of TGFBR2. Silence (2011) 1.53
Data publication consensus and controversies. F1000Res (2014) 1.32
The JCB DataViewer scales up. J Cell Biol (2012) 0.98
Non-specific effects of siRNAs on tumor cells with implications on therapeutic applicability using RNA interference. Pathol Oncol Res (2007) 0.92
The source of matrix-degrading enzymes in human cancer: Problems of research reproducibility and possible solutions. J Cell Biol (2015) 0.84